Complete Filing Data
Roman DBDR Acquisition Corp. II reported Stockholders Equity of -$778.1 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Roman DBDR Acquisition Corp. II did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income * | $7.7M |
| Operating Income Loss | -$2.3M |
| General And Administrative Expense | $2.3M |
| Other Nonoperating Income Expense | $10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Net Income * | $2.1M | $2.0M | $2.2M | -$90.7K |
| Operating Income Loss | -$513.3K | -$394.7K | -$341.4K | -$90.7K |
| General And Administrative Expense | $513.3K | $394.7K | $341.4K | $90.7K |
| Other Nonoperating Income Expense | $2.7M | $2.4M | $2.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$778.1K | $1.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $183.0K | $1.3M |
| Retained Earnings Accumulated Deficit | -$778.9K | $223.5K |
| Liabilities And Stockholders Equity | $241.5M | $202.8M |
| Assets Current | $317.7K | $1.4M |
| Assets | $241.5M | $202.8M |
| Other Liabilities Current | $70.00 | $70.00 |
| Liabilities Current | $895.8K | $301.8K |
| Assets Held In Trust Noncurrent | $241.2M | $201.3M |
| Accounts Payable And Accrued Liabilities Current | $895.7K | $20.5K |
| Remeasurement Of Temporary Equity To Redemption Value Adjustments | $10.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.1M | |
| Fair Value Adjustment Of Over Allotment Liability | -$268.8K | |
| Accrued Offering Costs Current | $2.1K | |
| Over Allotment Liability Current | $279.2K | |
| Remeasurement Of Temporary Equity To Redemption Value | $10.8M | |
| Notes Issued For Deferred Offering Costs Related Party | ||
| Liabilities | $1.1M | $301.8K |
| Deferred Offering Included In Accrued Offering Costs | ||
| Other Receivables Net Current | ||
| Deferred Offering Applied To Prepaid Expenses | ||
| Accrued Liabilities Current | $20.5K | |
| Accretion Of Temporary Equity To Redemption Value | ||
| Stockholders Equity Note Subscriptions Receivable | ||
| Reimbursement Receivable Current | $9.3K | |
| Notes Payable Current | ||
| Long Term Notes Payable | $200.0K | |
| Deferred Costs | ||
| Accretion Of Temporary Equity To Redemption Value Adjustments |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Stockholders Equity | $225.1K | $738.4K | $1.1M | -$90.7K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $323.7K | $618.8K | $948.5K | $0.00 |
| Retained Earnings Accumulated Deficit | $224.4K | $737.7K | $1.1M | -$90.7K |
| Liabilities And Stockholders Equity | $239.3M | $237.0M | $235.0M | $196.4K |
| Assets Current | $481.2K | $791.2K | $1.1M | $6.6K |
| Assets | $239.3M | $237.0M | $235.0M | $196.4K |
| Other Liabilities Current | $70.00 | $70.00 | $70.00 | |
| Liabilities Current | $275.6K | $98.5K | $75.0K | |
| Assets Held In Trust Noncurrent | $238.8M | $236.2M | $233.8M | |
| Accounts Payable And Accrued Liabilities Current | $275.5K | $98.4K | $75.0K | |
| Remeasurement Of Temporary Equity To Redemption Value Adjustments | $2.7M | $2.4M | $3.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$323.4K | $0.00 | ||
| Fair Value Adjustment Of Over Allotment Liability | -$268.8K | |||
| Accrued Offering Costs Current | $37.5K | |||
| Over Allotment Liability Current | ||||
| Remeasurement Of Temporary Equity To Redemption Value | ||||
| Notes Issued For Deferred Offering Costs Related Party | $147.0K | |||
| Liabilities | $287.2K | |||
| Deferred Offering Included In Accrued Offering Costs | $37.5K | |||
| Other Receivables Net Current | $5.8K | $20.2K | ||
| Deferred Offering Applied To Prepaid Expenses | $5.4K | |||
| Accrued Liabilities Current | $7.2K | |||
| Accretion Of Temporary Equity To Redemption Value | $3.3M | |||
| Stockholders Equity Note Subscriptions Receivable | $25.0K | |||
| Reimbursement Receivable Current | ||||
| Notes Payable Current | $242.5K | |||
| Long Term Notes Payable | ||||
| Deferred Costs | $189.8K | |||
| Accretion Of Temporary Equity To Redemption Value Adjustments | $3.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Payments For Investment Of Cash In Trust Account | $30.2M |
| Increase Decrease In Prepaid Expense | -$99.9K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $875.2K |
| Proceeds From Issuance Of Warrants | $750.0K |
| Net Cash Provided By Used In Operating Activities | -$1.3M |
| Net Cash Provided By Used In Investing Activities | -$30.2M |
| Net Cash Provided By Used In Financing Activities | $30.4M |
| Increase Decrease In Accrued Offering Costs | -$2.1K |
| Proceeds From Convertible Debt | $200.0K |
| Increase Decrease In Reimbursement Receivables | $9.3K |
| Increase Decrease In Accrued Liabilities |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 |
|---|---|---|
| Payments For Investment Of Cash In Trust Account | $30.2M | |
| Increase Decrease In Prepaid Expense | $34.4K | -$20.6K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $54.5K | $7.2K |
| Proceeds From Issuance Of Warrants | $750.0K | |
| Net Cash Provided By Used In Operating Activities | -$323.4K | |
| Net Cash Provided By Used In Investing Activities | -$30.2M | |
| Net Cash Provided By Used In Financing Activities | $30.2M | |
| Increase Decrease In Accrued Offering Costs | -$2.1K | |
| Proceeds From Convertible Debt | ||
| Increase Decrease In Reimbursement Receivables | ||
| Increase Decrease In Accrued Liabilities | $7.2K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Prepaid Expense Current | $125.4K | $127.0K |
| Prepaid Expense Noncurrent | $98.3K | |
| Investment Income Interest | $9.7M | |
| Sale Of Stock Consideration Received On Transaction | $29.4M | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $4.5K | |
| Additional Paid In Capital | $971.2K | |
| Payment Of Operating Costs By Sponsor Through Promissory Notes | ||
| Notes Issued For Prepaid Expenses | ||
| Formation Costs Applied To Prepaid Expenses Paid By Sponsor Through Promissory Notes | ||
| Operating And Formation Costs |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Prepaid Expense Current | $151.6K | $152.1K | $187.7K | $6.6K |
| Prepaid Expense Noncurrent | $19.5K | $45.8K | $72.0K | |
| Investment Income Interest | $2.7M | $2.4M | $2.3M | |
| Sale Of Stock Consideration Received On Transaction | $29.4M | |||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $4.5K | |||
| Additional Paid In Capital | $24.2K | |||
| Payment Of Operating Costs By Sponsor Through Promissory Notes | -$51.1K | |||
| Notes Issued For Prepaid Expenses | $44.4K | |||
| Formation Costs Applied To Prepaid Expenses Paid By Sponsor Through Promissory Notes | $11.9K | |||
| Operating And Formation Costs | $90.7K |
Most recent annual filing with the SEC: March 4, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.